Skip to main content
Premium Trial:

Request an Annual Quote

Roch Kelly, Reiner Westermeier

Premium
RainDance Technologies this week announced the appointment of Roch Kelly as Chief Operating Officer, effective immediately.
 
Prior to RainDance, Kelly was vice president of clinical operations for Synarc. His previous positions included Chief Operating Officer and Chief Financial Officer at Protedyne, and vice president of clinical operations and worldwide business at Parexel International. Kelly also served as executive director of manufacturing operations at Chiron Diagnostics.
 

 
Fluorotechnics has announced the appointment of Reiner Westermeier as its scientific marketing director.
 
Reiner was previously scientific support director for GE Healthcare, where he was responsible for the development of new electrophoresis systems, application development, and troubleshooting within the area of separations and analysis techniques used in proteomics.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.